Comparative effect of vincristine and alkylating agent No. 864 on rat leukemia in relation to the distribution of drugs and leukemic cells.
D000477:Alkylating Agents / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D000818:Animals; D001853:Bone Marrow / Q000378:metabolism / Q000473:pathology; D002460:Cell Line; D004353:Drug Evaluation, Preclinical; D005260:Female; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007942:Leukemia, Experimental / Q000188:drug therapy* / Q000473:pathology; D008698:Mesylates / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D009368:Neoplasm Transplantation; D011437:Propylamines / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use; D051381:Rats; D013154:Spleen / Q000378:metabolism / Q000473:pathology; D014316:Tritium; D014750:Vincristine / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*
D000477:Alkylating Agents; D008698:Mesylates; D011437:Propylamines; D014316:Tritium; D014750:Vincristine